DHR vs IMA · P/E 39, rev $24.57B vs rev $9.2M
Danaher Corporation (DHR) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. IMA currently screens at market cap $64.7M.
Not investment advice. Open the DHR and IMA stock pages for the full models.
Not investment advice.